VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A165-induced disturbances of barriers formed by retinal endothelial cells or long-term cultivated ARPE-19 cells

Heidrun L. Deissler*, Jan Niklas Stutzer, Gerhard K. Lang, Salvatore Grisanti, Gabriele E. Lang, Mahdy Ranjbar

*Corresponding author for this work
1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A165-induced disturbances of barriers formed by retinal endothelial cells or long-term cultivated ARPE-19 cells'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology